GYRE – gyre therapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

GYRE

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/13

06:00 am

gyre

Gyre Therapeutics Reports Third Quarter 2024 and Year-To-Date Financial Results and Provides Business Update

High Report

Gyre Therapeutics Reports Third Quarter 2024 and Year-To-Date Financial Results and Provides Business Update

Report

10/22

04:05 pm

gyre

Gyre Therapeutics Announces Last Patient Completed Pivotal Phase 3 Trial Evaluating F351 for CHB-Associated Liver Fibrosis

Low Report

Gyre Therapeutics Announces Last Patient Completed Pivotal Phase 3 Trial Evaluating F351 for CHB-Associated Liver Fibrosis

Report

10/4

10:36 am

gyre

Gyre Therapeutics, Inc.'s (NASDAQ:GYRE) market cap dropped US$51m last week; Public companies bore the brunt [Yahoo! Finance]

Medium Report

Gyre Therapeutics, Inc.'s (NASDAQ:GYRE) market cap dropped US$51m last week; Public companies bore the brunt [Yahoo! Finance]

Report

10/1

04:05 pm

gyre

Gyre Therapeutics to Present at 8th Annual H.C. Wainwright MASH Investor Conference

Medium Report

Gyre Therapeutics to Present at 8th Annual H.C. Wainwright MASH Investor Conference

Report

9/4

04:05 pm

gyre

Gyre Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference

Medium Report

Gyre Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.